Generation Bio Co (GBIO)
Last updated: 2026-10-22 20:26:40. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Summary
Generation Bio Co (GBIO) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalization of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- |
Generation Bio Co (GBIO) After-Hours Stock Price
Generation Bio Co (GBIO) is trading at $-- in after-hours trading as of --, -- from the regular-session close of $--.
After-hours trading shows how investors are pricing GBIO after the regular session closes. The current after-hours price is -- the regular-session close, indicating -- after-hours sentiment.
Generation Bio Co (GBIO) 7-Day Stock Price Change
Over the past seven days, Generation Bio Co (GBIO) moved from $5.53 to $5.34, representing a decline of 3.44% ($0.19).
The stock traded between $5.34 and $5.77 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 174.50 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
What is Generation Bio Co (GBIO)?
Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.
Generation Bio Co Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 115 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Generation Bio Co (GBIO) Stock on MEXC
Eligible investors can buy real shares of Generation Bio Co (GBIO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Generation Bio Co (GBIO) stock price today?
2.Is GBIO stock going up or down today?
3.What is GBIO pre-market price?
4.What is GBIO after-hours price?
5.Is GBIO stock trading now?
6.Where does GBIO sit relative to its 52-week high and low?
7.What sector is Generation Bio Co in?
8.What is Generation Bio Co's market capitalization and where is it listed?
9.How is GBIO valued in terms of P/E ratio and EPS?
10.Does Generation Bio Co pay a dividend?
Explore More US Stocks
Search Stocks
GBIO Stock Calculator
Estimate the value between GBIO shares and USD.
GBIO Shares to USD
1.00 GBIO shares = 0 USD
Calculations are estimates based on the latest available price and are for reference only.



